Digest Network Come funziona
Network
/
Società
Ha
Non verificato

Hansa Biopharma AB

Di cosa scriviamo

BiologiaEconomiaFarmaceuticaFitnessSanità

28 comunicati stampa

Guarda tutti i comunicati
27/05/2026
Salute
Fitness
Medicina - Varie
Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0
26/05/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0
19/05/2026
Salute
Fitness
Imprese
Industria
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Hansa Biopharma enters into €115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0
26/03/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Hansa Biopharma publishes 2025 Annual and Sustainability Reports
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0
04/03/2026
Salute
Fitness
PDUFA Action Date for Hansa Biopharma's Imlifidase BLA Set for December 19, 2026
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0
29/07/2025
Salute
Fitness
Medicina - Varie
Hansa Biopharma announces key executive appointments to support continued growth
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0
17/07/2025
Salute
Fitness
Economia
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0
08/07/2025
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Hansa Biopharma appoints Dr Richard Philipson as Chief Medical Officer
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0
11/06/2025
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Hansa Biopharma to attend BIO International Convention
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0
09/06/2025
Farmaceutica
Sanità
Media
Comunicazione
Multimedialità
Editoria elettronica
Biologia
Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025
Fonte
Hansa Biopharma AB
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0